As of 2026-01-05, the Relative Valuation of Crinetics Pharmaceuticals Inc (CRNX) is (48.04) USD. This relative valuation is based on P/E multiples. With the latest stock price at 46.73 USD, the upside of Crinetics Pharmaceuticals Inc based on Relative Valuation is -202.8%.
The range of the Relative Valuation is (34.33) - (65.37) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 5.2x - 14.7x | 10.0x |
| Forward P/E multiples | 7.7x - 15.5x | 11.6x |
| Fair Price | (34.33) - (65.37) | (48.04) |
| Upside | -173.5% - -239.9% | -202.8% |
| Date | P/E |
| 2026-01-02 | -10.48 |
| 2025-12-31 | -10.44 |
| 2025-12-30 | -10.63 |
| 2025-12-29 | -10.66 |
| 2025-12-26 | -10.76 |
| 2025-12-24 | -10.92 |
| 2025-12-23 | -10.96 |
| 2025-12-22 | -11.04 |
| 2025-12-19 | -10.77 |
| 2025-12-18 | -10.12 |
| 2025-12-17 | -10.70 |
| 2025-12-16 | -10.90 |
| 2025-12-15 | -11.06 |
| 2025-12-12 | -11.32 |
| 2025-12-11 | -11.06 |
| 2025-12-10 | -10.78 |
| 2025-12-09 | -10.74 |
| 2025-12-08 | -10.63 |
| 2025-12-05 | -10.47 |
| 2025-12-04 | -10.64 |
| 2025-12-03 | -10.54 |
| 2025-12-02 | -10.09 |
| 2025-12-01 | -10.15 |
| 2025-11-28 | -10.22 |
| 2025-11-26 | -10.32 |
| 2025-11-25 | -10.03 |
| 2025-11-24 | -9.83 |
| 2025-11-21 | -9.61 |
| 2025-11-20 | -9.41 |
| 2025-11-19 | -9.62 |
| 2025-11-18 | -9.65 |
| 2025-11-17 | -9.76 |
| 2025-11-14 | -9.57 |
| 2025-11-13 | -9.29 |
| 2025-11-12 | -9.60 |
| 2025-11-11 | -9.63 |
| 2025-11-10 | -9.30 |
| 2025-11-07 | -8.97 |
| 2025-11-06 | -9.75 |
| 2025-11-05 | -9.54 |
| 2025-11-04 | -9.53 |
| 2025-11-03 | -9.61 |
| 2025-10-31 | -9.76 |
| 2025-10-30 | -9.71 |
| 2025-10-29 | -9.62 |
| 2025-10-28 | -9.43 |
| 2025-10-27 | -9.94 |
| 2025-10-24 | -9.19 |
| 2025-10-23 | -8.99 |
| 2025-10-22 | -9.07 |